Authors

• Chaitra Banala (ORCID: https://orcid.org/0000-0002-9885-4674)
• Amit G. Singal (ORCID: https://orcid.org/0000-0002-1172-3971)
• Manasa Narasimman (ORCID: https://orcid.org/0000-0001-6838-8054)
• Rubén Hernáez (ORCID: https://orcid.org/0000-0002-1518-4020)
• Vanessa Cerda
• Sruthi Yekkaluri (ORCID: https://orcid.org/0000-0002-6246-6135)
• Darine Daher (ORCID: https://orcid.org/0000-0002-9977-1176)
• Caitlin C. Murphy (ORCID: https://orcid.org/0000-0001-9365-0691)
• Karim Seif El Dahan (ORCID: https://orcid.org/0000-0003-4268-4079)
• Jennifer R. Kramer (ORCID: https://orcid.org/0000-0003-2953-4949)
• Yan Liu (ORCID: https://orcid.org/0000-0001-5497-6197)
• MinJae Lee (ORCID: https://orcid.org/0000-0002-4329-506X)
• Aisha Khan

Institutions

• Parkland Health & Hospital System (US)
• Michael E. DeBakey VA Medical Center (US)
• Baylor College of Medicine (US)
• Center for Innovation (US)
• The University of Texas Southwestern Medical Center (US)

Publication Details

Journal

JNCI Journal of the National Cancer Institute

Published

2024-09-17

DOI

https://doi.org/10.1093/jnci/djae228

Citations

7

Primary Topic

Hepatocellular Carcinoma Treatment and Prognosis

Type

article

Field-Weighted Citation Impact

2.59

Funders

• Cancer Prevention and Research Institute of Texas
• Center for Innovations in Quality, Effectiveness and Safety
• National Cancer Institute